SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced ...

Transcarent will acquire Accolade for $7.03 per share in cash or $621 million in total. The transaction is expected to close during the 2025 second-quarter after gaining approval from Accolade ...

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, and virtual primary ...

Transcarent has announced its acquisition of Accolade for $7.03 per share in cash, totaling approximately $621 million, creating a combined company with over 1,400 employer and payer clients focused ...

Accolade is experiencing strong demand due to rising healthcare costs and employers seeking ways to reduce expenses. The company's proprietary technology platform and health assistants provide ...